Cognitive decline: A vitamin B perspective

Maturitas

Volumn 93, Issue , 2016, Pages 108-113

  Mikkelsen, Kathleen ^a   Stojanovska, Lily ^a   Tangalakis, Kathy ^a   Bosevski, Marijan ^b   Apostolopoulos, Vasso ^a  

^a VICTORIA UNIVERSITY   (Australia)

^b SS CYRIL AND METHODIUS UNIVERSITY OF SKOPJE   (Macedonia)

Author keywords

Ageing; Gerontology; Immune cells; Immune system; Inflammation

Indexed keywords

COBALAMIN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE; RIBOFLAVIN; THIAMINE; VITAMIN B GROUP; VITAMIN B COMPLEX;

ALZHEIMER DISEASE; COGNITIVE DEFECT; DEMENTIA; HUMAN; IMMUNOCOMPETENT CELL; REVIEW; RISK FACTOR; VITAMIN DEFICIENCY; VITAMIN SUPPLEMENTATION; BLOOD; COGNITION; DIETARY SUPPLEMENT; DRUG EFFECTS; MEMORY;

COGNITION; COGNITION DISORDERS; COGNITIVE DYSFUNCTION; DIETARY SUPPLEMENTS; HOMOCYSTEINE; HUMANS; MEMORY; VITAMIN B COMPLEX;

EID: 84992571521     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2016.08.001     Document Type: Review

References (45)

1. [1] Konar, A., Singh, P., Thakur, M.K., Age-associated cognitive decline: insights into molecular switches and recovery avenues. Aging Dis. 7 (2016), 121–129.
2. [2] Wilson, R.S., Barnes, L.L., Mendes de Leon, C.F., Aggarwal, N.T., Schneider, J.S., Bach, J., et al. Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology 59 (2002), 364–370.
3. [3] Erraji-Benchekroun, L., Underwood, M.D., Arango, V., Galfalvy, H., Pavlidis, P., Smyrniotopoulos, P., et al. Molecular aging in human prefrontal cortex is selective and continuous throughout adult life. Biol. Psychiatry 57 (2005), 549–558.
4. [4] Parker, W.D. Jr., Filley, C.M., Parks, J.K., Cytochrome oxidase deficiency in Alzheimer's disease. Neurology 40 (1990), 1302–1303.
5. [5] Mayeux, R., Stern, Y., Epidemiology of alzheimer disease. Cold Spring Harbor Perspect. Med., 2, 2012.
6. [6] Swerdlow, R.H., Pathogenesis of Alzheimer's disease. Clin. Interv. Aging 2 (2007), 347–359.
7. [7] Brenowitz, W.D., Nelson, P.T., Besser, L.M., Heller, K.B., Kukull, W.A., Cerebral amyloid angiopathy and its co-occurrence with Alzheimer's disease and other cerebrovascular neuropathologic changes. Neurobiol. Aging, 2015.
8. [8] Beydoun, M.A., Beydoun, H.A., Gamaldo, A.A., Teel, A., Zonderman, A.B., Wang, Y., Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta- analysis. BMC Public Health, 14, 2014, 643.
9. [9] Sachdev, P.S., Homocysteine and brain atrophy. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 29 (2005), 1152–1161.
10. [10] de Jager, C.A., Critical levels of brain atrophy associated with homocysteine and cognitive decline. Neurobiol. Aging 35:Suppl. 2 (2014), S35–9.
11. [11] Selhub, J., Bagley, L.C., Miller, J., Rosenberg, I.H., B vitamins, homocysteine, and neurocognitive function in the elderly. Am. J. Clin. Nutr. 71 (2000), 614S–620S.
12. [12] A. Yasko, Nutrigenomics and the methylation cycle. http://wwwdramyyaskocom/resources/autism-pathways-to-recovery/chapter-2/. 2015.
13. [13] Bottiglieri, T., Homocysteine and folate metabolism in depression. Prog. Neuro- Psychopharmacol. Biol. Psychiatry 29 (2005), 1103–1112.
14. [14] Jakubowski, J.A., Hatcher, N.G., Xie, F., Sweedler, J.V., The first gamma-carboxyglutamate-containing neuropeptide. Neurochem. Int. 49 (2006), 223–229.
15. [15] Obeid, R., Herrmann, W., Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett. 580 (2006), 2994–3005.
16. [16] Clarke, R., Smith, A.D., Jobst, K.A., Refsum, H., Sutton, L., Ueland, P.M., Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch. Neurol. 55 (1998), 1449–1455.
17. [17] Vogiatzoglou, A., Refsum, H., Johnston, C., Smith, S.M., Bradley, K.M., de Jager, C., et al. Vitamin B12 status and rate of brain volume loss in community-dwelling elderly. Neurology 71 (2008), 826–832.
18. [18] Kalmijn, S., Launer, L.J., Lindemans, J., Bots, M.L., Hofman, A., Breteler, M.M., Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam Study. Am. J. Epidemiol. 150 (1999), 283–289.
19. [19] Dauncey, M.J., Genomic and epigenomic insights into nutrition and brain disorders. Nutrients 5 (2013), 887–914.
20. [20] Tucker, K.L., Qiao, N., Scott, T., Rosenberg, I., Spiro, A. 3rd, High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study. Am. J. Clin. Nutr. 82 (2005), 627–635.
21. [21] Pepersack, T., Garbusinski, J., Robberecht, J., Beyer, I., Willems, D., Fuss, M., Clinical relevance of thiamine status amongst hospitalized elderly patients. Gerontology 45 (1999), 96–101.
22. [22] Terasawa, M., Nakahara, T., Tsukada, N., Sugawara, A., Itokawa, Y., The relationship between thiamine deficiency and performance of a learning task in rats. Metab. Brain Dis. 14 (1999), 137–148.
23. [23] Ciccia, R.M., Langlais, P.J., An examination of the synergistic interaction of ethanol and thiamine deficiency in the development of neurological signs and long-term cognitive and memory impairments. Alcohol. Clin. Exp. Res. 24 (2000), 622–634.
24. [24] Koh, F., Charlton, K., Walton, K., McMahon, A.T., Role of dietary protein and thiamine intakes on cognitive function in healthy older people: a systematic review. Nutrients 7 (2015), 2415–2439.
25. [25] ter Borg, S., Verlaan, S., Hemsworth, J., Mijnarends, D.M., Schols, J.M., Luiking, Y.C., et al. Micronutrient intakes and potential inadequacies of community-dwelling older adults: a systematic review. Br. J. Nutr. 113 (2015), 1195–1206.
26. [26] Pinto, J.T., Cooper, A.J., From cholesterogenesis to steroidogenesis: role of riboflavin and flavoenzymes in the biosynthesis of vitamin D. Adv. Nutr. 5 (2014), 144–163.
27. [27] Moat, S.J., Ashfield-Watt, P.A., Powers, H.J., Newcombe, R.G., McDowell, I.F., Effect of riboflavin status on the homocysteine-lowering effect of folate in relation to the MTHFR (C677T) genotype. Clin. Chem. 49 (2003), 295–302.
28. [28] Garcia-Minguillan, C.J., Fernandez-Ballart, J.D., Ceruelo, S., Rios, L., Bueno, O., Berrocal-Zaragoza, M.I., et al. Riboflavin status modifies the effects of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) polymorphisms on homocysteine. Genes Nutr., 9, 2014, 435.
29. [29] Goodwin, J.S., Goodwin, J.M., Garry, P.J., Association between nutritional status and cognitive functioning in a healthy elderly population. JAMA 249 (1983), 2917–2921.
30. [30] Hvas, A.M., Juul, S., Bech, P., Nexo, E., Vitamin B6 level is associated with symptoms of depression. Psychother. Psychosom. 73 (2004), 340–343.
31. [31] Malouf, R., Grimley Evans, J., The effect of vitamin B6 on cognition. Cochrane Database Syst. Rev., 2003 (CD004393).
32. [32] Balk, E., Chung, M., Raman, G., Tatsioni, A., Chew, P., Ip, S., et al. B vitamins and berries and age- related neurodegenerative disorders. Evid. Rep./Technol. Assess., 2006, 1–161.
33. [33] Douaud, G., Refsum, H., de Jager, C.A., Jacoby, R., Nichols, T.E., Smith, S.M., et al. Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 9523–9528.
34. [34] Cacciapuoti, F., Lowering homocysteine levels with folic acid and B-vitamins do not reduce early atherosclerosis, but could interfere with cognitive decline and Alzheimer's disease. J. Thromb. Thrombolysis 36 (2013), 258–262.
35. [35] Solomons, N.W., Food fortification with folic acid: has the other shoe dropped. Nutr. Rev. 65 (2007), 512–515.
36. [36] Weir, D.G., Scott, J.M., Brain function in the elderly: role of vitamin B12 and folate. Br. Med. Bull. 55 (1999), 669–682.
37. [37] Marzena, Z., Jerzy, L., [The importance of folic acid deficiency in the pathogenesis of vascular, mixed and Alzheimer's disease dementia]. Polski merkuriusz lekarski: organ Polskiego Towarzystwa Lekarskiego 35 (2013), 205–209.
38. [38] Jerneren, F., Elshorbagy, A.K., Oulhaj, A., Smith, S.M., Refsum, H., Smith, A.D., Brain atrophy in cognitively impaired elderly: the importance of long-chain omega-3 fatty acids and B vitamin status in a randomized controlled trial. Am. J. Clin. Nutr. 102 (2015), 215–221.
39. [39] Oulhaj, A., Jerneren, F., Refsum, H., Smith, A.D., de Jager, C.A., Omega-3 fatty acid status enhances the prevention of cognitive decline by B vitamins in mild cognitive impairment. J. Alzheimer's Dis. 50 (2016), 547–557.
40. [40] Remington, R., Bechtel, C., Larsen, D., Samar, A., Page, R., Morrell, C., et al. Maintenance of cognitive performance and mood for individuals with Alzheimer's disease following consumption of a nutraceutical formulation: a one-year, open-label study. J. Alzheimer's Dis. 51 (2016), 991–995.
41. [41] Horvat, P., Gardiner, J., Kubinova, R., Pajak, A., Tamosiunas, A., Schottker, B., et al. Serum folate, vitamin B-12 and cognitive function in middle and older age: the HAPIEE study. Exp. Gerontol. 76 (2016), 33–38.
42. [42] Agnew-Blais, J.C., Wassertheil-Smoller, S., Kang, J.H., Hogan, P.E., Coker, L.H., Snetselaar, L.G., et al. Folate, vitamin B-6, and vitamin B-12 intake and mild cognitive impairment and probable dementia in the Women's Health Initiative Memory Study. J. Acad. Nutr. Diet. 115 (2015), 231–241.
43. [43] van der Zwaluw, N.L., Dhonukshe-Rutten, R.A., van Wijngaarden, J.P., Brouwer-Brolsma, E.M., van de Rest, O., In ‘t Veld, P.H., et al. Results of 2-year vitamin B treatment on cognitive performance: secondary data from an RCT. Neurology 83 (2014), 2158–2166.
44. [44] Health Quality, O., Vitamin B12 and cognitive function: an evidence-based analysis. Ontario Health Technol. Assess. Ser. 13 (2013), 1–45.
45. [45] Knapp, M., Prince, M., Dementia UK.–A report into the prevalence and cost of dementia prepared by the personal social services research unit (PSSRU) at the London school of economics and the institute of psychiatry at king's college London, for alzheimer's society, London. Alzheimer's Soc., 2007 Updated 2015.